<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="27/05/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9919536" creator="Noriko Katsu">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9919536</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Inhibition of <term sem="Other" id="T1" lex="NF-kappa_B_activation"><term sem="Protein_complex" id="T2" lex="NF-kappa_B">NF-kappa B</term> activation</term> in vitro and in vivo: role of <term sem="Protein_complex" id="T3" lex="26S_proteasome">26S proteasome</term>.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="T2" />
<clue>Inhibition of NF-kappa B <clueType>activation</clueType> in vitro and in vivo: role of 26S proteasome.</clue>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="E1" />
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation in vitro and in vivo: role of 26S proteasome.</clue>
</event>
<event id="E3">
<type class="Regulation" />
<theme idref="E1" />
<cause idref="T3" />
<clue>Inhibition of NF-kappa B activation in vitro and in vivo: <clueType>role</clueType> <linkCause>of</linkCause> 26S proteasome.</clue>
<comment>NO LINKTHEME</comment>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">It is becoming increasingly apparent that <term sem="Protein_complex" id="T4" lex="NF-kappa_B">NF-kappa B</term> plays a critical role in regulating the <term sem="Other" id="T5" lex="inflammatory_response">inflammatory response</term>.</sentence>
<event id="E4">
<type class="Regulation" />
<theme idref="E20" />
<cause idref="T4" />
<clue>It is becoming increasingly apparent that NF-kappa B <clueType>plays</clueType> a critical <clueType>role</clueType> <linkTheme>in</linkTheme> regulating the inflammatory response.</clue>
</event>
<event id="E20">
<type class="Regulation" />
<theme idref="T5" />
<clue>It is becoming increasingly apparent that NF-kappa B plays a critical role in <clueType>regulating</clueType> the inflammatory response.</clue>
</event>
<sentence id="S3">Data obtained from studies in our laboratories demonstrate that the <term sem="Protein_complex" id="A1">proteasome</term> plays an important role in the <term sem="Other" id="T6" lex="inflammatory_cascade">inflammatory cascade</term> by regulating the activation of <term sem="Protein_complex" id="T7" lex="NF-kappa_B">NF-kappa B</term>.</sentence>
<event id="E5">
<type class="Regulation" />
<theme idref="T6" />
<cause idref="E6" />
<clue>Data obtained from studies in our laboratories demonstrate that the proteasome <clueType>plays</clueType> an important <clueType>role</clueType> <linkTheme>in</linkTheme> the inflammatory cascade <linkCause>by</linkCause> regulating the activation of NF-kappa B.</clue>
</event>
<event id="E6">
<type class="Regulation" />
<theme idref="E7" />
<cause idref="A1" />
<clue>Data obtained from studies in our laboratories demonstrate that the proteasome plays an important role in the inflammatory cascade by <clueType>regulating</clueType> the activation of NF-kappa B.</clue>
</event>
<event id="E7">
<type class="Positive_regulation" />
<theme idref="T7" />
<clue>Data obtained from studies in our laboratories demonstrate that the proteasome plays an important role in the inflammatory cascade by regulating the <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B.</clue>
</event>
<sentence id="S4">Indeed, the availability of selective and <term sem="Organic_compound_other" id="T8" lex="orally_active_proteasome_inhibitor">orally active <term sem="Organic_compound_other" id="A2">proteasome inhibitors</term></term> should prove useful in delineating the roles of the <term sem="Cell_component" id="T9" lex="proteasome">proteasome</term> and <term sem="Protein_complex" id="T10" lex="NF-kappa_B">NF-kappa B</term> in other <term sem="Other" id="T11" lex="pathophysiological_condition">pathophysiological conditions</term> such as <term sem="Other" id="T12" lex="cancer">cancer</term> and <term sem="Other" id="T13" lex="heart_disease">heart disease</term>.</sentence>
<event uncertainty="probable" id="E8">
<type class="Negative_regulation" />
<theme idref="E16" />
<cause idref="A2" />
<clue>Indeed, the availability of selective and orally active proteasome inhibitors should prove useful in <clueType>delineating</clueType> the roles of the proteasome and NF-kappa B in other pathophysiological conditions such as cancer and heart disease.</clue>
</event>
<event uncertainty="probable" id="E9">
<type class="Negative_regulation" />
<theme idref="E17" />
<cause idref="A2" />
<clue>Indeed, the availability of selective and orally active proteasome inhibitors should prove useful in <clueType>delineating</clueType> the roles of the proteasome and NF-kappa B in other pathophysiological conditions such as cancer and heart disease.</clue>
</event>
<event uncertainty="probable" id="E10">
<type class="Negative_regulation" />
<theme idref="E18" />
<cause idref="A2" />
<clue>Indeed, the availability of selective and orally active proteasome inhibitors should prove useful in <clueType>delineating</clueType> the roles of the proteasome and NF-kappa B in other pathophysiological conditions such as cancer and heart disease.</clue>
</event>
<event uncertainty="probable" id="E11">
<type class="Negative_regulation" />
<theme idref="E19" />
<cause idref="A2" />
<clue>Indeed, the availability of selective and orally active proteasome inhibitors should prove useful in <clueType>delineating</clueType> the roles of the proteasome and NF-kappa B in other pathophysiological conditions such as cancer and heart disease.</clue>
</event>
<event id="E16">
<type class="Regulation" />
<theme idref="T12" />
<cause idref="T9" />
<clue>Indeed, the availability of selective and orally active proteasome inhibitors should prove useful in delineating the <clueType>roles</clueType> <linkCause>of</linkCause> the proteasome and NF-kappa B <linkTheme>in</linkTheme> <corefTheme>other pathophysiological conditions</corefTheme> such as cancer and heart disease.</clue>
<comment>NER: T9 sem mod, Cell_component -&gt; Protein_complex</comment>
</event>
<event id="E17">
<type class="Regulation" />
<theme idref="T13" />
<cause idref="T9" />
<clue>Indeed, the availability of selective and orally active proteasome inhibitors should prove useful in delineating the <clueType>roles</clueType> <linkCause>of</linkCause> the proteasome and NF-kappa B <linkTheme>in</linkTheme> <corefTheme>other pathophysiological conditions</corefTheme> such as cancer and heart disease.</clue>
<comment>NER: T9 sem mod, Cell_component -&gt; Protein_complex</comment>
</event>
<event id="E18">
<type class="Regulation" />
<theme idref="T12" />
<cause idref="T10" />
<clue>Indeed, the availability of selective and orally active proteasome inhibitors should prove useful in delineating the <clueType>roles</clueType> <linkCause>of</linkCause> the proteasome and NF-kappa B <linkTheme>in</linkTheme> <corefTheme>other pathophysiological conditions</corefTheme> such as cancer and heart disease.</clue>
</event>
<event id="E19">
<type class="Regulation" />
<theme idref="T13" />
<cause idref="T10" />
<clue>Indeed, the availability of selective and orally active proteasome inhibitors should prove useful in delineating the <clueType>roles</clueType> <linkCause>of</linkCause> the proteasome and NF-kappa B <linkTheme>in</linkTheme> <corefTheme>other pathophysiological conditions</corefTheme> such as cancer and heart disease.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
